C12N 2501/2333
Interleukin-33
Official title: Interleukin-33 (IL-33)
C12N2501/2333 (Interleukin-33) appears on 8 US grants and 31 published applications in this corpus.
Search patents in C12N- Granted patents
- 8
- Published applications
- 31
- Assignees
- 23
- Inventors
- 60
- Latest grant
- 4 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 0 | 2 |
| 2016 | 0 | 0 |
| 2017 | 0 | 2 |
| 2018 | 0 | 3 |
| 2019 | 0 | 3 |
| 2020 | 0 | 2 |
| 2021 | 1 | 4 |
| 2022 | 2 | 3 |
| 2023 | 2 | 5 |
| 2024 | 1 | 1 |
| 2025 | 2 | 1 |
| 2026 | 0 | 5 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Expansion of γδ T cells, compositions, and methods of use thereof4 Nov 2025US 12,458,698 B2GammaDelta Therapeutics Ltd
- Methods for improving cognitive function14 Oct 2025US 12,440,513 B2Albany Medical College
- Methods and reagents for modulating macrophage phenotype25 Jun 2024US 12,016,881 B2New York University
- Human innate lymphoid cell precursors: identification, characterization, applications20 Jun 2023US 11,680,245 B2Institut National De La Sante Et De La Recherche Medicale (Inserm)
- Expansion of γδ T cells, compositions, and methods of use thereof23 May 2023US 11,655,453 B2GammaDelta Therapeutics Ltd
- Method for producing group 2 innate lymphoid cells24 Sep 2026US 2026/0286297 A1Astellas Pharma Inc.
- Expansion of gamma delta t cells, compositions, and methods of use thereof25 Jun 2026US 2026/0174861 A1GammaDelta Therapeutics Ltd
- Innate lymphoid cells for cell therapy and biomarkers therefor18 Jun 2026US 2026/0166081 A9University Health Network
- T cell production method23 Apr 2026US 2026/0109949 A1Kyoto University
- Methods for improving cognitive function2 Apr 2026US 2026/0091063 A1Albany Medical College
Most cited
By later US patents